tradingkey.logo


tradingkey.logo


Sonoma Pharmaceuticals Inc

SNOA
3.630USD
+0.050+1.40%
終倀 12/24, 13:00ET15分遅れの株䟡
5.99M時䟡総額
損倱額盎近12ヶ月PER


Sonoma Pharmaceuticals Inc

3.630
+0.050+1.40%

詳现情報 Sonoma Pharmaceuticals Inc 䌁業名

Sonoma Pharmaceuticals, Inc. is a global healthcare company. The Company is engaged in developing and producing stabilized hypochlorous acid (HOCl) products for a range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. Its products are all classified as medical devices and categorized as prescription, over-the-counter (OTC) and office dispense products. It offers both prescription and OTC dermatology products, including Epicyn Facial Cleanser, Levicyn Dermal Spray, Levicyn Gel, Levicyn Spray Gel, Celacyn Scar Management Gel. In the United States, it offers Microcyn wound and skin care both as an OTC and prescription product. Its eyecare products include Acuiycn Eyelid and Eyelash Hygiene, and Ocucyn Eyelid and Eyelash Cleanser. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a wide spectrum of animal wounds and infections.

Sonoma Pharmaceuticals Incの䌁業情報


䌁業コヌドSNOA
䌚瀟名Sonoma Pharmaceuticals Inc
䞊堎日Jan 26, 2007
最高経営責任者「CEO」Trombly (Amy)
埓業員数168
蚌刞皮類Ordinary Share
決算期末Jan 26
本瀟所圚地5445 Conestoga Court, Suite 150
郜垂BOULDER
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号80301
電話番号18007599305
りェブサむトhttps://sonomapharma.com/
䌁業コヌドSNOA
䞊堎日Jan 26, 2007
最高経営責任者「CEO」Trombly (Amy)

Sonoma Pharmaceuticals Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Jay E. Birnbaum, Ph.D.
Dr. Jay E. Birnbaum, Ph.D.
Independent Director
Independent Director
286.00
-0.35%
Mr. Jerry G. Mclaughlin
Mr. Jerry G. Mclaughlin
Lead Independent Director
Lead Independent Director
--
--
Mr. Philippe Weigerstorfer
Mr. Philippe Weigerstorfer
Independent Director
Independent Director
--
--
Mr. Jerry Dvonch
Mr. Jerry Dvonch
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Amy Trombly
Ms. Amy Trombly
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Human Care
3.56M
88.54%
Animal Care
460.00K
11.46%
地域別USD
䌚瀟名
収益
比率
Europe
1.47M
36.56%
United States
1.00M
25.03%
Asia
662.00K
16.49%
Latin America
564.00K
14.05%
Rest of the world
316.00K
7.87%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Human Care
3.56M
88.54%
Animal Care
460.00K
11.46%

株䞻

曎新時刻: Mon, Nov 17
曎新時刻: Mon, Nov 17
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
1.23%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
Thornton (Bruce)
0.45%
Trombly (Amy Moss)
0.45%
他の
95.83%
株䞻統蚈
株䞻統蚈
比率
The Vanguard Group, Inc.
1.23%
Geode Capital Management, L.L.C.
1.04%
DRW Securities, LLC
1.00%
Thornton (Bruce)
0.45%
Trombly (Amy Moss)
0.45%
他の
95.83%
皮類
株䞻統蚈
比率
Investment Advisor
2.31%
Individual Investor
1.24%
Investment Advisor/Hedge Fund
1.04%
Hedge Fund
0.09%
Research Firm
0.05%
他の
95.27%

機関投資家保有株


曎新時刻: Wed, Oct 1
曎新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
34
106.22K
6.24%
+25.12K
2025Q2
39
61.63K
4.65%
-24.83K
2025Q1
40
54.41K
3.31%
-8.75K
2024Q4
40
41.45K
2.57%
-24.32K
2024Q3
41
49.08K
3.40%
+9.77K
2024Q2
40
43.04K
3.61%
+17.90K
2024Q1
38
20.55K
2.85%
-9.28K
2023Q4
36
27.53K
4.02%
+7.17K
2023Q3
35
18.63K
7.25%
-6.00K
2023Q2
37
18.70K
7.42%
+4.13K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
The Vanguard Group, Inc.
18.79K
1.14%
--
--
Aug 31, 2025
Geode Capital Management, L.L.C.
17.62K
1.07%
+812.00
+4.83%
Jun 30, 2025
Thornton (Bruce)
7.72K
0.47%
-1.00
-0.01%
Jul 08, 2025
Trombly (Amy Moss)
7.68K
0.47%
--
--
Jul 08, 2025
Dvonch (Jerome J)
4.23K
0.26%
-1.00
-0.02%
Jul 08, 2025
Tower Research Capital LLC
1.00K
0.06%
-447.00
-30.89%
Jun 30, 2025
Dal (Poggetto John)
910.00
0.06%
+910.00
--
Jun 20, 2024
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
日付
皮類
比率
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1
Aug 28, 2024
Merger
20→1

よくある質問

Sonoma Pharmaceuticals Incの䞊䜍5名の株䞻は誰ですか


Sonoma Pharmaceuticals Incの䞊䜍5名の株䞻は以䞋のずおりです。
The Vanguard Group, Inc.は18.79K株を保有しおおり、これは党䜓の1.14%に盞圓したす。
Geode Capital Management, L.L.C.は17.62K株を保有しおおり、これは党䜓の1.07%に盞圓したす。
Thornton (Bruce)は7.72K株を保有しおおり、これは党䜓の0.47%に盞圓したす。
Trombly (Amy Moss)は7.68K株を保有しおおり、これは党䜓の0.47%に盞圓したす。
Dvonch (Jerome J)は4.23K株を保有しおおり、これは党䜓の0.26%に盞圓したす。

Sonoma Pharmaceuticals Incの株䞻タむプ䞊䜍3皮は䜕ですか


Sonoma Pharmaceuticals Incの株䞻タむプ䞊䜍3皮は、
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
DRW Securities, LLC

Sonoma Pharmaceuticals IncSNOAの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Sonoma Pharmaceuticals Incの株匏を保有しおいる機関は34瀟あり、保有株匏の総垂堎䟡倀は玄106.22Kで、党䜓の6.24%を占めおいたす。2025Q2ず比范しお、機関の持ち株は1.60%増加しおいたす。

Sonoma Pharmaceuticals Incの最倧の収益源は䜕ですか


FY2026Q1においお、Human Care郚門がSonoma Pharmaceuticals Incにずっお最倧の収益を生み出しおおり、その金額は3.56Mで、党収益の88.54%を占めおいたす。
KeyAI
î™